News & Blog
Investigators and colleagues associated with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) conducted primary and secondary economic analyses using data collected from the X:BOT trial.
This summer, Sona Fokum and Weston Lowry are interning at the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) and expanding their research experience by working alongside CHERISH investigators and colleagues.
Why are Black patients less likely than white patients to be prescribed opioids for acute pain in the emergency department (ED)?
While a variety of efforts are needed to address the opioid overdose crisis, one promising strategy is to leverage hospitalization to initiate patients on buprenorphine.
CHERISH shared a national call for health economic research proposals focusing on health and health care disparities, and selected four recipients to receive the seventh cycle of pilot grant funding from 2021 to 2022.
Findings do not support the notion that policies aimed at enhancing prescription drug monitoring programs led to increases in abrupt discontinuation of long-term opioid therapy but the majority of discontinuations occurred without tapering.